Medpace Holdings

MEDP75

High Quality

$337.75arrow_drop_down1.12%-$3.85

High Quality

MEDP75

$337.75

arrow_drop_down1.12%-$3.85

High Quality

Performance History

Key Stats
Open	$340.45
Prev. Close	$341.82
EPS	11.42
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-

	LOW	HIGH
Day Range	337.07	349.77
52 Week Range	227.21	459.76

Ratios







EPS	11.42

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Medpace Holdings (MEDP)

Medpace Holdings Inc. (MEDP) is a global contract research organization (CRO) that provides fully integrated clinical research services, including designing and conducting all phases of clinical trials for pharmaceutical, biotechnology, and medical device companies. The company's services also include regulatory support, project management, data management, statistical analysis, and medical writing. Medpace has a strong track record of successfully delivering high-quality clinical trials on time and within budget, which has enabled it to build long-term relationships with its clients.

Medpace's business model is based on a highly specialized and experienced team of clinical research professionals who have deep therapeutic and regulatory knowledge. The company's employees have an average of 20 years of industry experience, and many hold advanced degrees in medicine, pharmacy, or life sciences. This expertise allows Medpace to provide customized solutions to its clients and to navigate the complex regulatory landscape effectively.

Websitecall_made

Sector: Healthcare
Industry: Diagnostics & Research
CEO: Dr. August James Troendle M.D.
Headquarters: Cincinnati
Employees: 5400
Exchange: NASDAQ

Keep an eye on Medpace Holdings

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Medpace Holdings 's (MEDP) price per share?

The current price per share for Medpace Holdings (MEDP) is $337.75. The stock has seen a price change of -$3.86 recently, indicating a -1.13% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Medpace Holdings (MEDP)?

For Medpace Holdings (MEDP), the 52-week high is $459.77, which is 36.13% from the current price. The 52-week low is $227.21, the current price is 48.65% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Medpace Holdings (MEDP) a growth stock?

Medpace Holdings (MEDP) has shown an average price growth of -3.66% over the past three years. It has received a score of 71 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Medpace Holdings as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Medpace Holdings (MEDP) stock price performance year to date (YTD)?

As of the latest data, Medpace Holdings (MEDP) has a year-to-date price change of 10.52%. Over the past month, the stock has experienced a price change of 2.33%. Over the last three months, the change has been -13.6%. Over the past six months, the figure is -13.53%. Looking at a longer horizon, the five-year price change stands at 342.89%.

help

Is Medpace Holdings (MEDP) a profitable company?

Medpace Holdings (MEDP) has a net income of $282.81M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 27.81% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 21.05% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $1.89B, with a revenue growth rate of 29.17%, providing insight into the company's sales performance and growth. The gross profit is $524.5M. Operating income is noted at $336.82M. Furthermore, the EBITDA is $439.73M.

help

What is the market capitalization of Medpace Holdings (MEDP)?

Medpace Holdings (MEDP) has a market capitalization of $10.5B. The average daily trading volume is 341.02, indicating the stock's liquidity and investor engagement.

News

MEDPACE HOLDINGS

SECURITIES LAW VIOLATIONS

NET BOOK-TO-BILL RATIO

Nov 12, 2024

MEDP Investigation: Kessler Topaz Meltzer & Check, LLP Encourages Medpace Holdings, Inc. (NASDAQ: MEDP) Investors with Significant Losses to Contact the Firm

MEDPACE HOLDINGS, INC.

JEFFERIES FINANCIAL GROUP INC.

SECURITIES LAW VIOLATIONS

Nov 1, 2024

Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating Medpace Holdings, Inc. for potential violations of securities laws

MEDP INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Medpace Holdings, Inc. and Encourages Investors to Contact the Firm

MEDPACE HOLDINGS

NASDAQ: MEDP

FINANCIAL RESULTS

NET BOOK-TO-BILL RATIO

STOCK PRICE

Oct 25, 2024

NASDAQ: MEDP Investigation: Kessler Topaz Meltzer & Check, LLP Encourages Medpace Holdings, Inc. (NASDAQ: MEDP) Investors with Significant Losses to Contact the Firm

MEDPACE HOLDINGS

CONTRACT RESEARCH ORGANIZATION

FINANCIAL PERFORMANCE

Medpace Holdings (MEDP) Reveals “Shocking” Bookings Miss, Shares Fall - Hagens Berman